Insulin glargine, recombinant Subcutaneous and Zemplar (Paricalcitol Injection)
Determining the interaction of Insulin glargine, recombinant Subcutaneous and Zemplar (Paricalcitol Injection) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: paricalcitol
Brand name: Zemplar
Synonyms: Zemplar
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine, recombinant Subcutaneous-Zemplar Injection
- Insulin glargine, recombinant Subcutaneous-Zemplar Intravenous
- Insulin glargine, recombinant Subcutaneous-Zemuron
- Insulin glargine, recombinant Subcutaneous-Zenapax
- Insulin glargine, recombinant Subcutaneous-Zenatane
- Insulin glargine, recombinant Subcutaneous-Zenchent
- Zemplar (Paricalcitol Injection)-Insulin glulisine
- Zemplar (Paricalcitol Injection)-Insulin Glulisine (Cartridges and Pens)
- Zemplar (Paricalcitol Injection)-Insulin Glulisine (Vials)
- Zemplar (Paricalcitol Injection)-Insulin glulisine Subcutaneous
- Zemplar (Paricalcitol Injection)-Insulin human inhaled Inhalation
- Zemplar (Paricalcitol Injection)-Insulin human regular Injection